The AD/PD™ series of conferences have always been notable for an excellent program that balances cutting-edge scientific research and advanced clinical discussions.

AD/PD™ 2025 will continue that tradition with sessions of Forum Discussions, Symposia, Oral and Poster Presentations devoted to latest breakthroughs in treatment, translational R&D, early diagnosis, drug development and clinical trials in Alzheimer’s, Parkinson’s and other related neurological disorders.